Hospital Universitario Príncipe de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (40)

2023

  1. Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

    Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901

  2. SER recommendations for the treatment of uveitis

    Reumatologia Clinica, Vol. 19, Núm. 9, pp. 465-477

  3. The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

    PLoS ONE, Vol. 18, Núm. 2 February

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection

    Journal of Pediatrics, Vol. 241, pp. 126-132.e3

  3. Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience

    Cancers, Vol. 14, Núm. 7

2021

  1. Article a multicenter analysis of the outcome of cancer patients with neutropenia and covid-19 optionally treated with granulocyte-colony stimulating factor (G-csf): A comparative analysis

    Cancers, Vol. 13, Núm. 16

  2. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  3. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

    Leukemia and Lymphoma, Vol. 62, Núm. 12, pp. 2928-2938

  4. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  5. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2099-2106

  6. Protocolised odontological assessment of patients with primary Sjögren's syndrome

    Reumatologia Clinica, Vol. 17, Núm. 1, pp. 25-31

2020

  1. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

  2. Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer

    Cancer Biology and Medicine, Vol. 17, Núm. 2, pp. 444-457

  3. Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics

    Anales de Pediatria, Vol. 92, Núm. 4, pp. 239-240

  4. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224

  5. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study

    Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828

2019

  1. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease

    Clinical Rheumatology, Vol. 38, Núm. 3, pp. 803-815

2018

  1. All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real-world practice: Madrid coinfection registry findings

    Hepatology, Vol. 68, Núm. 1, pp. 32-47

  2. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38